Dr. Reddy's Wants Teva's Coreg Claims Bounced

Law360, New York (September 4, 2007, 12:00 AM EDT) -- Dr. Reddy's Laboratories Inc. has fought back against Teva Pharmaceutical Industries Ltd. in the battle over GlaxoSmithKline Inc.'s drug Coreg, saying a lawsuit that seeks to bar Dr. Reddy's from marketing a generic version of the congestive heart failure treatment should be scrapped because all claims of the asserted patents are invalid.

In court documents filed Friday in the U.S. District Court for the District of New Jersey, Dr. Reddy's said that it denied the allegations in Teva's complaint, filed June 21, and that “each and...
To view the full article, register now.